Healthcare Deals This Week: Omada, Antares, Amplify
The healthcare industry saw a few notable deals this past week, including a much-anticipated IPO from digital health company Omada and a handful of private fundraises among startups.
23andMe Auction Is A Wake-Up Call For Data Privacy Law
With its giant trove of customer genetic and health data up for auction, direct-to-consumer genetic testing company 23andMe's bankruptcy is revealing glaring gaps in federal data privacy laws.
Drug Cos. Face Persistent Scrutiny Over Physician Kickbacks
Drugmakers continue to become ensnared in 鈥� and settle 鈥� investigations into illegal payments to healthcare providers for participating in sham speaker programs. These payments raise ethical questions about patient harm and whether they are seen as a cost of doing business.
Healthcare Deals This Week: Omada, Antares, Amplify
The healthcare industry saw a few notable deals this past week, including a much-anticipated IPO from digital health company Omada and a handful of private fundraises among startups.
23andMe Auction Is A Wake-Up Call For Data Privacy Law
With its giant trove of customer genetic and health data up for auction, direct-to-consumer genetic testing company 23andMe's bankruptcy is revealing glaring gaps in federal data privacy laws.
Drug Cos. Face Persistent Scrutiny Over Physician Kickbacks
Drugmakers continue to become ensnared in 鈥� and settle 鈥� investigations into illegal payments to healthcare providers for participating in sham speaker programs. These payments raise ethical questions about patient harm and whether they are seen as a cost of doing business.
Expert Analysis
Recent analyses of the Section 340B program's effectiveness in helping patients afford drugs in Minnesota reinforc... (more story)
The U.S. Food and Drug Administration recently touted the completion of a generative artificial intelligence progr... (more story)
Under the current antitrust agency leadership, the latest course in merger enforcement, regulatory approach and ke... (more story)
Deals & Corporate Governance More
AbbVie Inc. on Thursday filed suit in Colorado federal court seeking to block an incoming state law it alleges conflicts with the federal 340B drug discount program by forcing pharmaceutical manufacturers to s... (more story)
Health technology company Tempus AI Inc. and two of its executives face a shareholder class action over claims the company misrepresented its artificial intelligence capabilities, the value of its contracts an... (more story)
A Swedish medical device company has sued Georgia-based MedWay Group Inc. in federal court for allegedly infringing its patents for foam dressings used in wound care and management.
German biotech firm BioNTech SE said Thursday that it will acquire CureVac NV, a clinical-stage mRNA specialist, in an all-stock oncology-focused deal valuing it at about $1.25 billion and involving five legal advisers.聽
Clinical-stage biotech company PepGen Inc. has been hit with a proposed shareholder class action alleging it misled investors about the efficacy and commercial prospects of its muscular dystrophy drug, causing... (more story)
An Illinois federal judge seemed skeptical Tuesday that health benefit plans accusing Biogen of impairing competition for聽its multiple sclerosis drug, Tecfidera, have standing to bring their lawsuit under deca... (more story)
Digital Health & Technology More
A number of university scholars urged a Missouri bankruptcy judge to require that DNA testing company 23andMe聽Holding Co.'s asset sale be contingent on the final buyer maintaining policies that benefit biomedical researchers.
Healthcare technology company Omnicell Inc. has agreed to pay more than $4.3 million to settle allegations it fraudulently overcharged the U.S. Department of Veterans Affairs for medical products and software,... (more story)
A bipartisan coalition of 28 attorneys general has sued 23andMe Inc. in Missouri bankruptcy court seeking to block the genetic-testing company from auctioning off its 15 million customers' personal genetic inf... (more story)
PointClickCare is urging a Maryland federal court to toss a case seeking to force the medical records company to allow Real Time Medical Systems to access patient data with automated bots after the Fourth Circ... (more story)
The FDA's speedy adoption of Elsa, its new artificial intelligence tool, is raising questions about how it was trained and safeguards around AI-generated hallucinations.
A California federal judge allowed a proposed class action accusing Google of illicitly scooping up users' personal data from healthcare providers' websites to continue Friday, but only for certain claims base... (more story)
Policy & Compliance More
A Massachusetts federal judge on Monday blocked the National Institutes of Health from cutting hundreds of grant programs to universities, hospitals and other organizations, saying that in his 40 years on the ... (more story)
The U.S. Supreme Court on Monday rejected Merck Sharp & Dohme Corp.'s request to review a Third Circuit decision that more than 1,000 failure-to-warn claims over its osteoporosis drug Fosamax can continue desp... (more story)
The U.S. Supreme Court on Monday agreed to review the Third Circuit's dismissal of an anti-abortion pregnancy center's federal lawsuit challenging a subpoena from the New Jersey attorney general demanding info... (more story)
Innovative Health is seeking a permanent injunction that would ban Johnson & Johnson health tech unit Biosense Webster from conditioning the provision of cardiac mapping services on purchases of cardiac cathet... (more story)
The Fifth Circuit has ruled a pair of flight ambulance providers cannot pursue their lawsuit seeking to enforce out-of-network billing dispute resolution awards against a health insurance company, saying there... (more story)
The New York-based owner of a Berks County, Pennsylvania, home care agency has been sentenced to spend a month in jail and repay $235,778 in fraudulently billed Medicaid claims, the Pennsylvania Attorney Gener... (more story)